John Herberger
Director Técnico/Científico/I+D en ELEDON PHARMACEUTICALS, INC. .
Perfil
John Herberger is currently the Vice President-Technical Operations at Eledon Pharmaceuticals, Inc. He previously worked as the Senior Director-Manufacturing Science & Technology at Spark Therapeutics, Inc. and as a Member at the Institute of Molecular Biology.
He completed his undergraduate degree at the State University of New York at Albany.
Cargos activos de John Herberger
Empresas | Cargo | Inicio |
---|---|---|
ELEDON PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/05/2022 |
Antiguos cargos conocidos de John Herberger.
Empresas | Cargo | Fin |
---|---|---|
Institute of Molecular Biology | Corporate Officer/Principal | - |
SPARK THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Formación de John Herberger.
State University of New York at Albany | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ELEDON PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- John Herberger